Postmenopausal Symptoms Clinical Trial
Official title:
Effects of Isoflavone and Estrogen in Sex Response in Climacteric Women
NCT number | NCT00905723 |
Other study ID # | 0759/08 |
Secondary ID | |
Status | Unknown status |
Phase | Phase 3 |
First received | May 19, 2009 |
Last updated | May 19, 2009 |
Start date | May 2009 |
Climacterium is marked by hypoestrogenism and it is associated to drastic vasomotors symptoms, genital atrophy and humor alteration. Additionally, these symptoms impair sexual life and life quality. These effects can be counteracted by administration of estrogen therapy. However, estrogen therapy has side effects and isoflavone has been proposed as an estrogen substitute in reposition therapy. The aim of the randomized controlled trial is to evaluate the effects of isoflavone in the sex life assessed by a modified McCoy's sexual questionnaire.
Status | Unknown status |
Enrollment | 60 |
Est. completion date | |
Est. primary completion date | May 2010 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 45 Years to 65 Years |
Eligibility |
Inclusion Criteria: - women aged 45-65 years old - presenting climacteric symptoms - sexual complaints Exclusion Criteria: - hormonal therapy - counter indication to hormonal therapy - uncontrolled comorbidities |
Country | Name | City | State |
---|---|---|---|
Brazil | Ambulatório de Ginecologia Endócrina | São Paulo |
Lead Sponsor | Collaborator |
---|---|
Federal University of São Paulo |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | McCoy's sexual questionnaire | at recruitment and six months later | ||
Secondary | Kupperman's index | at recruitment and six months later |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06369363 -
Estrogen Deficiency on Cardiovascular Risk
|
Early Phase 1 | |
Not yet recruiting |
NCT01170195 -
Effectiveness of Licorice Extract Dietary Supplement on the Treatment of Postmenopausal Symptoms
|
Phase 1/Phase 2 | |
Completed |
NCT00535288 -
Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013)
|
Phase 3 | |
Recruiting |
NCT06030388 -
Strength and Aerobic Training Against Hot Flushes in Postmenopausal Women
|
N/A | |
Not yet recruiting |
NCT05557799 -
Photobiomodulation in Post Menopause Genitourinary Syndrome
|
Phase 1/Phase 2 | |
Recruiting |
NCT04893226 -
Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women
|
N/A | |
Completed |
NCT03684096 -
Effect of Non-estrogenic Pollen Extract PCC-100 on Hot Flushes
|
N/A | |
Completed |
NCT01268046 -
Aging and Estrogen on Cortical Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05659693 -
The Effect of Digital Literacy Education Given to Postmenopausal Women on Health Literacy and Quality of Life
|
N/A | |
Completed |
NCT03572153 -
A Mind-Body Intervention for Hot Flash Management
|
N/A | |
Not yet recruiting |
NCT06419972 -
Multimodal Program for Climacteric Women
|
N/A | |
Not yet recruiting |
NCT06197568 -
Open-Label Study of Vaginal AZU-101 in Postmenopausal Women
|
Phase 1/Phase 2 | |
Withdrawn |
NCT03854396 -
Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal Women
|
Phase 3 | |
Completed |
NCT01361308 -
Efficacy/Safety Study of Brisdelleā¢ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS)
|
Phase 3 | |
Recruiting |
NCT05351476 -
Exercise Training and Fat Metabolism in Postmenopausal Women
|
N/A | |
Completed |
NCT06096818 -
Kegel and Abdominal Exercises on Urinary Incontinence Severity, Quality of Life, and Sleep Quality in Menopausal Women
|
N/A | |
Completed |
NCT03150407 -
Use of J3 Bioscience Lubricating Intravaginal Ring VR101 to Relieve the Symptoms of Vaginal Dryness
|
N/A | |
Recruiting |
NCT06220266 -
Effects of Phytoestrogen From Pueraria Mirifica in Improvement of Serum Lipid Parameters in Postmenopausal Women
|
Phase 2/Phase 3 | |
Recruiting |
NCT04129060 -
Cholinergic Health After Menopause (CHAMP)
|
Early Phase 1 | |
Recruiting |
NCT06028009 -
PRP Injections for Genitourinary Syndrome of Menopause
|
N/A |